Advertisement

Topics

eXIthera Presents Clinical Data on Novel Small Molecule FXIa Inhibitor EP-7041 at American ...

15:45 EST 13 Nov 2017 | BioMedReports - Blog

Antithrombotic EP-7041 safe and well tolerated; performed in antithrombotic test range associated with clinical efficacy and with fast onset/offset of activity

WESTBOROUGH, MA--(Marketwired - Nov

Read more...

Original Article: eXIthera Presents Clinical Data on Novel Small Molecule FXIa Inhibitor EP-7041 at American ...

NEXT ARTICLE

More From BioPortfolio on "eXIthera Presents Clinical Data on Novel Small Molecule FXIa Inhibitor EP-7041 at American ..."

Advertisement
Quick Search
Advertisement
Advertisement